286 related articles for article (PubMed ID: 30602372)
1. PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer.
Al-Khadairi G; Naik A; Thomas R; Al-Sulaiti B; Rizly S; Decock J
J Transl Med; 2019 Jan; 17(1):9. PubMed ID: 30602372
[TBL] [Abstract][Full Text] [Related]
2. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
[TBL] [Abstract][Full Text] [Related]
3. Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.
Lv ZD; Yang ZC; Liu XP; Jin LY; Dong Q; Qu HL; Li FN; Kong B; Sun J; Zhao JJ; Wang HB
J Cell Mol Med; 2016 Sep; 20(9):1640-50. PubMed ID: 27027510
[TBL] [Abstract][Full Text] [Related]
4. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol enhances the sensitivity of FL118 in triple-negative breast cancer cell lines via suppressing epithelial to mesenchymal transition.
Yar Saglam AS; Kayhan H; Alp E; Onen HI
Mol Biol Rep; 2021 Jan; 48(1):475-489. PubMed ID: 33389483
[TBL] [Abstract][Full Text] [Related]
6. SNAI1-mediated transcriptional regulation of epithelial-to-mesenchymal transition genes in breast cancer stem cells.
Singh D; Deshmukh RK; Das A
Cell Signal; 2021 Nov; 87():110151. PubMed ID: 34537302
[TBL] [Abstract][Full Text] [Related]
7. MiR-1976 knockdown promotes epithelial-mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis.
Wang J; Li M; Han X; Wang H; Wang X; Ma G; Xia T; Wang S
Cell Death Dis; 2020 Jul; 11(7):500. PubMed ID: 32620748
[TBL] [Abstract][Full Text] [Related]
8. α-Linolenic acid inhibits the migration of human triple-negative breast cancer cells by attenuating Twist1 expression and suppressing Twist1-mediated epithelial-mesenchymal transition.
Wang SC; Sun HL; Hsu YH; Liu SH; Lii CK; Tsai CH; Liu KL; Huang CS; Li CC
Biochem Pharmacol; 2020 Oct; 180():114152. PubMed ID: 32679125
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells.
Zhang Y; Tian J; Qu C; Peng Y; Lei J; Li K; Zong B; Sun L; Liu S
Breast Cancer; 2021 Jul; 28(4):859-873. PubMed ID: 33569740
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of a Glycolytic Signature and Its Regulation by Y-Box-Binding Protein 1 in Triple-Negative Breast Cancer.
Lai YW; Hsu WJ; Lee WY; Chen CH; Tsai YH; Dai JZ; Yang CC; Lin CW
Cells; 2021 Jul; 10(8):. PubMed ID: 34440660
[TBL] [Abstract][Full Text] [Related]
11. VSP‑17 suppresses the migration and invasion of triple‑negative breast cancer cells through inhibition of the EMT process via the PPARγ/AMPK signaling pathway.
Xu X; Liu M; Yang Y; Wei C; Zhang X; Song H; Wang Y; Duan X
Oncol Rep; 2021 Mar; 45(3):975-986. PubMed ID: 33650675
[TBL] [Abstract][Full Text] [Related]
12. Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation.
Shome R; Ghosh SS
Cell Oncol (Dordr); 2021 Apr; 44(2):405-422. PubMed ID: 33398673
[TBL] [Abstract][Full Text] [Related]
13. SALL4 promotes tumor progression in breast cancer by targeting EMT.
Chen T; Tsang JYS; Su XC; Li P; Sun WQ; Wong ILK; Choy KY; Yang Q; Tse GMK; Chan TH; Chow LMC
Mol Carcinog; 2020 Oct; 59(10):1209-1226. PubMed ID: 32835442
[TBL] [Abstract][Full Text] [Related]
14. HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway.
Xu J; Fang X; Long L; Wang S; Qian S; Lyu J
Cancer Biol Ther; 2021 Jan; 22(1):5-11. PubMed ID: 33307962
[TBL] [Abstract][Full Text] [Related]
15. miR-770-5p regulates EMT and invasion in TNBC cells by targeting DNMT3A.
Noyan S; Andac Ozketen A; Gurdal H; Gur Dedeoglu B
Cell Signal; 2021 Jul; 83():109996. PubMed ID: 33798630
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid A1: Innocent bystander or active participant in cell migration in triple-negative breast cancer?
Olivier DW; Pretorius E; Engelbrecht AM
Exp Cell Res; 2021 Sep; 406(1):112759. PubMed ID: 34332984
[TBL] [Abstract][Full Text] [Related]
17. DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation.
Liu J; Li H; Mao A; Lu J; Liu W; Qie J; Pan G
Cell Cycle; 2020 Dec; 19(24):3622-3631. PubMed ID: 33300431
[TBL] [Abstract][Full Text] [Related]
18. STAT3-induced NCK1 elevation promotes migration of triple-negative breast cancer cells via regulating ERK1/2 signaling.
He P; Sheng J; Qi J; Bai X; Li J; Wang F; Yuan Y; Zheng X
Mol Biol Rep; 2022 Jan; 49(1):267-278. PubMed ID: 34846647
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer.
Huang YH; Chu PY; Chen JL; Huang CT; Huang CC; Tsai YF; Wang YL; Lien PJ; Tseng LM; Liu CY
Sci Rep; 2021 Jun; 11(1):12171. PubMed ID: 34108545
[TBL] [Abstract][Full Text] [Related]
20. E2F3 drives the epithelial-to-mesenchymal transition, cell invasion, and metastasis in breast cancer.
Jusino S; Rivera-Rivera Y; Chardón-Colón C; Ruiz-Justiz AJ; Vélez-Velázquez J; Isidro A; Cruz-Robles ME; Bonilla-Claudio M; Armaiz-Pena GN; Saavedra HI
Exp Biol Med (Maywood); 2021 Oct; 246(19):2057-2071. PubMed ID: 34365840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
